Adamantyl-Substituted Chalcone CA13 Induces Cytoprotective Autophagy and JNK-Dependent Apoptosis in Lung Cancer Cells
Biomolecules · 2025
DOI: 10.3390/biom16010054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Yuting Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Hubei University of Science and Technology, Xianning 437100, China. Hauptthemen laut MEDLINE: Autophagy, Apoptosis, Lung Neoplasms, Chalcone. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Health Commission of Hubei Province Scientific Research Project, the National Natural Science Foundation of China, the Hubei Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
Lung cancer remains a leading cause of cancer mortality worldwide, highlighting the need for novel therapeutics. Here, we designed and synthesized a series of adamantyl-substituted chalcones and identified CA13 as a lead compound with potent and selective antiproliferative activity against non–small cell lung cancer (NSCLC) cells. CA13 triggered both apoptosis and autophagy in H292 cells. Western blotting and confocal imaging confirmed the activation of complete autophagic flux, while inhibition of autophagy markedly enhanced CA13-induced apoptosis, suggesting a cytoprotective role of autophagy. Mechanistically, CA13 activated JNK phosphorylation in a dose- and time-dependent manner, and pharmacological blockade of JNK significantly attenuated apoptotic signaling. In vivo, CA13 effectively suppressed H292 xenograft tumor growth without apparent systemic toxicity. Collectively, these results demonstrate that CA13 exerts its antitumor effects through JNK-dependent apoptosis accompanied by cytoprotective autophagy, providing a promising structural framework for the development of chalcone-based anticancer agents targeting programmed cell death pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Hubei University of Science and Technology, Xianning 437100, China.
- Institutes of Biomedical Science, Inner Mongolia University, Hohhot 010021, China.
- Xiantao First People's Hospital, The Affiliated Hospital of Hubei University of Science and Technology, Xiantao 433000, China.
Förderung
- the Health Commission of Hubei Province Scientific Research Project
- the National Natural Science Foundation of China
- the Hubei Provincial Natural Science Foundation of China
- the Doctoral Research Fund of Hubei University of Science and Technology
- Health Commission of Hubei Province Scientific Research Project
- National Natural Science Foundation of China
- Hubei Provincial Natural Science Foundation of China
- Doctoral Research Fund of Hubei University of Science and Technology
Zitieren
APA
Chen, Y., Liu, Y., Zhou, J., Bao, T., Wang, J., & Ao, M. (2025). Adamantyl-Substituted Chalcone CA13 Induces Cytoprotective Autophagy and JNK-Dependent Apoptosis in Lung Cancer Cells. Biomolecules. https://doi.org/10.3390/biom16010054
Vancouver
Chen Y, Liu Y, Zhou J, Bao T, Wang J, Ao M. Adamantyl-Substituted Chalcone CA13 Induces Cytoprotective Autophagy and JNK-Dependent Apoptosis in Lung Cancer Cells. Biomolecules. 2025. doi:10.3390/biom16010054
BibTeX
@article{Chen2025,
author = {Chen, Yuting and Liu, Yaxin and Zhou, Jing and Bao, Tingting and Wang, Jing and Ao, Mingtao},
title = {Adamantyl-Substituted Chalcone CA13 Induces Cytoprotective Autophagy and JNK-Dependent Apoptosis in Lung Cancer Cells},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom16010054}
}
EUVIMED